Jason Hope Donates $500,000 to SENS Research Foundation

SENS Research foundation, a regenerative medical research non-profit institution based in Mountain View, California is making significant head room in anti-aging techniques and treatment. Through the donations of various philanthropists such as Jason Home has been able to develop drugs significant in combating aging effects.Aging can be a costly affair to deal with especially when it is caused by ailments such as Alzheimer’s disease and Parkinson’s disease. Such ailments contain advanced glycation end products or AGEs that accelerate aging prematurely. This is something that Jason hopes to mitigate and therefore his generous donation towards SENS Research Foundation. Jason believes that accurate tackling of aging diseases in the human body is a good futuristic approach to dealing with a very expensive problem.

Through Jason Hope’s donations and other philanthropists as well, SENS Research Institute has been able to develop the Cambridge SENS Laboratory that has progressed research in stem cell experimentation to identify anti-aging solutions.This is important because in the past, anti-aging experiments had been carried out on lab animals that have short life spans; therefore, even though the research findings were positive, they proved ineffective when tried on humans that have a longer life span.Through the continued support of Jason Home who propagates the significance of anti-aging research technique, SENS has been able to carry out targeted and backed up experimentation, inching closer toward dealing with aging ailments.

So who is Jason Hope?

Jason Hope is an entrepreneur, tech enthusiast, philanthropist and futurist. He was born and raised in Tempe Arizona where he has been able to get a degree in Finance at the Arizona State University.He later acquired an MBA in the scope of business.He is a well-known entrepreneur as a result of his numerous business ideas funding in the field of technology. He has been able to fund business ideas from young techpreneurs who are in need of start-up funds and the funding varies from case to case.He has been able to get a lot of recognition for his propagation of Internet of Things as he is a firm believer in the fact that the future is greatly dependent on the interconnectivity of smart devices to the internet and seamless communication between them. This has informed majority of his investment decisions. His philanthropic tendencies, as demonstrated above, have also contributed greatly to the field of science and medical research.

Jeremy Goldstein: Businesses Without Stock Options

It’s hard to think about the corporate world without stock options, but that’s quickly the way the world’s going. Over the last few years, hundreds of corporations have stopped providing their employees with stock options for a number of reasons. Obviously, most people think it’s money-related, but that’s not exactly true.

While money does play a big role in most corporations’ decision-making process, saving money isn’t the only reason they’re getting rid of stock options. A lot of it has to do with their employees wanting higher wages or better insurance coverage instead of traditional stock options.

These days, people are more conscious about where their money is at all times. Too often, a company goes under and leaves its employees hanging, as they stock value plummets and crashes. When stock value drops too low, the stock becomes useless and cannot be exercised.

People don’t want their hard work to go to waste just because an executive or the economy does something wrong. In those cases, everything gets reported and possibly places shareholders at the risk of facing overhang, which isn’t as bad as worthless stocks but pretty close to it. In fact, that’s a major reason corporations are no longer offering stock options. Learn more: http://clsbluesky.law.columbia.edu/author/jeremy-l-goldstein/

Also, stock options come with huge tax burdens that may not make them worth the trouble. Accountants have to do a lot to ensure every employee gets what they deserve, and that takes a very long time and a lot of financial assistance; at the end of the day, stock options are too expensive.

As hard as stock options can be, experts like Jeremy Goldstein suggest they have their place in modern business. Not every corporation needs to get rid of stock options; especially if equivalency is a big deal with employees.

The last 15 years, Jeremy Goldstein has become New York’s number one executive compensation and corporate governance attorney. Everyone goes to him when it comes to advice about which compensation method to use. Jeremy Goldstein usually recommends stock options to his big-name clients.

When Goldstein isn’t working with clients like Verizon, he’s donating his time to local charities like Fountain House. Fountain House works with patients with mental illness and focuses on their full recovery.

Dr. David B. Samadi, the Prostate Surgeon with a Heart

Dr. David B. Samadi is a renowned board-certified urologist. He treats patients for a host of diseases including bladder cancer, prostate cancer, and kidney cancer. Samadi is the Chairman of Urology and the Chief of Robotic Surgery at Lenox Hill Hospital in New York City.

Dr. David B. Samadi was born in Iran and in 1979 immigrated to Europe in his teens with his family. He obtained some of his secondary education there before moving to New York where he graduated high school. His college and medical school attendance is as follows:

  • Stony Brook University, Majored in Biochemistry on full scholarship
  • S.U.N.Y. Stony Brook School of Medicine, Medical Doctor Degree, 1994
  • Montefiore Medical Center, Post Graduate urology training, 1996
  • Albert Einstein, Post Graduate proctology training, 2000
  • Memorial Sloan Kettering Cancer Center, Oncology Fellowship in Proctology, 2001
  • Henri Mondor Hospital Creteil in France, Robotic Radical Prostatectomy Fellowship, 2002

In 2012, he gained notoriety as being the highest paid doctor in NY City, earning $7.6 million a year. His first practice was at Columbia Presbyterian Hospital on the upper Westside of Manhattan. In 2007, he moved to Mt. Sinai School of Medicine and in 2013, he moved to Lenox Hill Hospital.

In July 2015, Samadi educated doctors at the Mediterranean Hospital of Cyprus about the robotic procedures he customarily used and he performed surgeries utilizing those techniques. Many of Dr. Samadi’s successes can be directly associated with the Samadi Modified Advanced Robotic Treatment that he invented. He has used this specific treatment for more than 7,000 prostate cancer surgeries and he has successfully helped 90% of those patients became cancer free. Designed to replace traditional surgery, the Samadi Modified Advanced Robotic Treatment (SMART) is a minimally invasive version of the da Vinci Surgical System.

Dr. Samadi urges men to get tested well before the age of 60, which was once the standard. Early detection quite often results in a positive outcome. He notes that 90% of those whose disease is detected early get cured.

A member of the American Medical Association and of the American Urologic Association, Dr. Samadi often gives presentations and speeches at national and international medical conferences. David B Samadi is not only one of the best prostate surgeon, he is a doctor dedicated to the successful and compassionate treatment of prostate cancer. It’s his goal to help all ages of men preserve their highest quality of life after prostate surgery.

Paul Mampilly, an Investment Guru Who Spends His Time Helping a Common Man Rise in the Financial Ranks

Paul Mampilly was born in India. He later moved to the United States at the age of 18. He went to Montclair State University and graduated with a degree in finance and accounting. Years later, he earned an MBA from Fordham University. Additionally, he studied economics as well as financial engineering. Currently, he lives in Durham, where he concentrates on research in investment opportunities and writing for financial publications. His newsletter, Profits Unlimited, is one of the fastest growing publication in the finance field. Though it is one year old, it already has over 90,000 annual subscribers. These subscriptions are evidence of how investors follow the Mampilly’s work. Many upcoming investors like to read the advice of Mampilly due to his proven success. In 2009, he invested $50 million which yielded $88 million, something that led him to win the Templeton Foundation’s investment competition.

Paul Mampilly served as the assistant portfolio manager of the Bankers Trust in 1991. As his experience advanced in the investment sector, he secured a prominent position at the legal firm. During his tenure at the Kinetics Asset Management, where he handled the hedge fund of the company, he saw the assets of the company grow to $25 billion, which was considered as one of the best returns in the world by Barron.When Paul Mampilly became tired of making money for the ultra-rich, he had an option of spending more time at home with his family. Presently, he is still in the finance industry where he works as a researcher and investment analyst. It is his pleasure to help the ordinary people make money.Many of the Paul Mampilly’s newsletters give people the techniques on how they can invest and better their lives.

In most cases, he features at the Bloomberg TV, CNBC, as well as the Fox Business News.In an interview, when asked how he started his business, Paul Mampilly said that he started his own business after he became tired of making money for the Wall Street. He said that he was only helping the rich get richer, something he thought that was not fair.On how he makes money, he said that he follows the market and track particular companies. Through trading, he can invest his money and that of others. He keeps things simple and maintain essential buying and selling patterns.About his satisfying moment in business, Mampilly mentions that it was when he was leaving Wall Street. Now that he is helping those individuals who are saving for their retirements, it makes him feel happy.